VST

IppocraTech is a biotechnology startup based in Italy that aims to revolutionize the healthcare industry. Founded in 2017, the company's slogan "Health through innovation" encapsulates its mission. IppocraTech has developed a groundbreaking technology that can simultaneously calculate the 5 vitals identified by the WHO to assess a person's health status. This innovative device collects signals needed by IppocraTech's algorithms in the cloud to monitor heart rate and respiration, body temperature, blood saturation, one-lead ECG, and blood pressure by simply touching the device. Notably, the technology has been patented and received CE Class IIa certification. It has also been approved through clinical studies in some important Italian hospitals and featured in international medical journals. With its potential to disrupt the biotechnology and healthcare sectors, IppocraTech presents an exciting investment opportunity for venture capitalists seeking to support cutting-edge innovations in the field of health and wellness.